Genetic Testing Following Type A Thoracic Aortic Dissection — The Good, the Bad and the Ugly
Genetic testing is indicated for suspected familial thoracic aortic aneurysm or following dissection to complement targeted screening of first-degree relatives. Our data suggest that tissue storage and genetic testing in the setting of suspected heritable thoracic aortic aneurysm and dissection (HTAAD) are underutilized. In this focussed review, we outline the genetic basis of HTAAD and the current guidelines regarding genetic testing. We present a case series demonstrating both favourable and unfavourable genetic testing practices. We suggest potential improvements to current genetic testing algorithms, such as increased involvement of medical examiners and emergency department clinicians, to help identify patients and families suitable for genetic testing. Additionally, we provide a description of the pathophysiology underlying inheritable aortopathies.
Authors
- Sam Straw (ORCID: https://orcid.org/0000-0002-2942-4574)
- Kathryn J Griffin (ORCID: https://orcid.org/0000-0002-3154-3273)
- Mary Walker
- Wazir Baig
- Carl Simela (ORCID: https://orcid.org/0009-0003-0324-8482)
- Paraskevi-Maria Psefteli
Institutions
- University of Leeds (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
Publication Details
- Journal
- British Journal of Hospital Medicine
- Published
- 2025-12-04
- DOI
- https://doi.org/10.12968/hmed.2024.0984
- Primary Topic
- Aortic Disease and Treatment Approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00